As Principal Biostatistician you will provide high level expertise in the specialist area of Research Biostatistics. You will support research activities in alignment with the respective Therapeutic Area (TA) Research Strategies. In collaboration with Research teams contribute statistical input towards experimental designs, statistical analyses, interpretation and reporting of research studies, to ensure efficient use of resources as well as robust conclusions and deliveries following regulatory requirements and guidelines. The position plays a key role in executing research strategies, fostering internal and external partnerships, and ensuring delivery of impactful preclinical and translational science packages that support clinical development and business objectives.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
